{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:31:27Z","timestamp":1790771487250,"version":"4.1.0"},"reference-count":69,"publisher":"Korean Endocrine Society","issue":"1","license":[{"start":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T00:00:00Z","timestamp":1646006400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["e-enm.org"],"crossmark-restriction":true},"short-container-title":["Endocrinol Metab"],"published-print":{"date-parts":[[2022,2,28]]},"abstract":"<jats:p>Guidelines for the management of patients with diabetes have become an important part of clinical practice that improve the quality of care and help establish evidence-based medicine in this field. With rapidly accumulating evidence on various aspects of diabetes care, including landmark clinical trials of treatment agents and newer technologies, timely updates of the guidelines capture the most current state of the field and present a consensus. As a leading academic society, the Korean Diabetes Association publishes practice guidelines biennially and the American Diabetes Association does so annually. In this review, we summarize the key changes suggested in the most recent guidelines. Some of the important updates include treatment algorithms emphasizing comorbid conditions such as atherosclerotic cardiovascular disease, heart failure, and chronic kidney disease in the selection of anti-diabetic agents; wider application of continuous glucose monitoring (CGM), insulin pump technologies and indices derived from CGM such as time in range; more active screening of subjects at high-risk of diabetes; and more detailed individualization in diabetes care. Although there are both similarities and differences among guidelines and some uncertainty remains, these updates provide a good approach for many clinical practitioners who are battling with diabetes.<\/jats:p>","DOI":"10.3803\/enm.2022.105","type":"journal-article","created":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T03:14:01Z","timestamp":1646018041000},"page":"26-37","update-policy":"https:\/\/doi.org\/10.3803\/crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["Recent Updates to Clinical Practice Guidelines for Diabetes Mellitus"],"prefix":"10.3803","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4967-9862","authenticated-orcid":true,"given":"Jin","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3964-3877","authenticated-orcid":true,"given":"Seung-Hwan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3205-9114","authenticated-orcid":true,"given":"Mee Kyoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2119","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2021.0156"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1504720"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1253\/circj.cj-16-1148"},{"key":"ref4","first-page":"121","volume-title":"Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomized placebo-controlled trial","author":"Gerstein","year":"2019"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1603827"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1607141"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1812389"},{"key":"ref8","first-page":"1413","volume-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","author":"Packer","year":"2020"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1515920"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2024816"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2016.9607"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(15)00803-x"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.2713"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(18)30297-6"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.7326\/m16-2855"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2021.04.008"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.4158\/cs-2019-0472"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.19975"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2018.0252"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.17925\/ee.2018.14.1.24"},{"key":"ref21","first-page":"1593","volume-title":"Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range","author":"Battelino","year":"2019"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.277818"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.2337\/figshare.13618910.v1"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.2337\/dc22-sint"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.2337\/dc22-srev"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.2337\/dc22-s003"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.2337\/dc22-s007"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.2337\/dc22-s009"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(19)32131-2"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-8587(19)30184-6"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-1957"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-1495"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.1252"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2108269"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.2337\/dc22-s010"},{"key":"ref36","first-page":"1995","volume-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","author":"McMurray","year":"2019"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2030183"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.2064"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.2337\/dc22-s011"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1811744"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2025845"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.120.051898"},{"key":"ref43","first-page":"2262","volume-title":"Effect of continuous glucose monitoring on glycemic control in patients with type 2 diabetes treated with basal insulin: a randomized clinical trial","author":"Martens","year":"2021"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-021-01086-y"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.2337\/dc22-s014"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-020-01366-0"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjms.2020.07.005"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1177\/1932296820923045"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-020-01089-2"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa342"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1177\/1932296820964264"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.2337\/dc22-s016"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.2337\/dci21-0043"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-009088"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp16x684961"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-019-4863-8"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1016\/1047-2797(93)90004-n"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-0636"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1177\/1932296818822496"},{"key":"ref60","first-page":"e54","volume-title":"Response to Comment on Soupal et al. Glycemic outcomes in adults with T1D are impacted more by continuous glucose monitoring than by insulin delivery method: 3 years of follow-up from the COMISAIR Study. Diabetes Care 2020;43:37\u201343","author":"Soupal","year":"2020"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.11708"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1907863"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1097\/mot.0000000000000786"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1177\/0145721720987926"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.13306"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.12024"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1007\/s13340-020-00471-5"},{"key":"ref68","first-page":"B21","volume-title":"Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients","author":"Shichiri","year":"2000"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1007\/s13340-016-0293-8"}],"container-title":["Endocrinology and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/e-enm.org\/upload\/pdf\/enm-2022-105.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/e-enm.org\/journal\/view.php?doi=10.3803\/EnM.2022.105","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/e-enm.org\/upload\/pdf\/enm-2022-105.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T01:52:16Z","timestamp":1682992336000},"score":1,"resource":{"primary":{"URL":"http:\/\/e-enm.org\/journal\/view.php?doi=10.3803\/EnM.2022.105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,28]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"URL":"https:\/\/doi.org\/10.3803\/enm.2022.105","relation":{},"ISSN":["2093-596X","2093-5978"],"issn-type":[{"value":"2093-596X","type":"print"},{"value":"2093-5978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,28]]},"assertion":[{"value":"2022-01-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-06","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-28","order":2,"name":"published","label":"Published online","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-28","order":3,"name":"published","label":"Print publication","group":{"name":"publication_history","label":"Publication History"}}]}}